Eligible participants are VA, IHS, BOP, fhcc and ordering facilities under the DOD prime vendor program.
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79720D0049
- Awardee
-
Xlcare Pharmaceuticals Inc. UEI MEAUS5WHBJJ7
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Lamivudine_Zidovudine Tablets Pre-Solicitation · 36E79720R0052 · Posted Jun 4, 2020
- 6505--Lamivudine 150MG/Zidovudine 300MG Tablets Award Notice · Posted Jul 17, 2020
- 6505--Lamivudine_Zidovudine Tablets Solicitation · Posted Jun 10, 2020
- Last date to order 100% complete
- IDV ceiling
- $3,129,016.00
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business that is certified as an economically disadvantaged woman-owned small business.
The contract has a total ceiling value of $3,129,016.00 and a period of performance from November 16, 2020 to November 15, 2025. It is a single-award IDC that allows for the ordering of various pharmaceutical products by the VA, Indian Health Service, Bureau of Prisons, and Department of Defense through the VA's Pharmaceutical Prime Vendor program. The key pharmaceutical products included are losartan potassium tablets, lamivudine/zidovudine combination tablets, lacosamide injections, dutasteride capsules, gabapentin capsules, pantoprazole tablets, levetiracetam tablets, montelukast sodium tablets, and aripiprazole tablets. This contract supports the VA's Consolidated Mail Outpatient Pharmacy (CMOP) program and distributes pharmaceuticals to VA medical centers.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79720D0049?
36E79720D0049 was awarded to Xlcare Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on November 16, 2020.
How much is contract 36E79720D0049 worth?
36E79720D0049's own ceiling is $3,129,016.
Who can order from contract 36E79720D0049?
36E79720D0049 is a single award indefinite delivery contract.
Was contract 36E79720D0049 competed?
The extent of competition for 36E79720D0049 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV